New Century Financial Group’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
– Sell
-510
Closed -$258K – 308
2024
Q3
$258K Sell
510
-13
-2% -$6.32K 0.09% 259
2024
Q2
$255K Buy
523
+101
+24% +$50.7K 0.11% 231
2024
Q1
$228K Sell
422
-520
-55% -$284K 0.16% 159
2023
Q4
$523K Buy
+942
New +$442K 0.45% 80

Other funds holding IDXX

New Century Financial Group's IDXX Position: Q4 2024 in Review

New Century Financial Group sold out of Idexx Laboratories (IDXX) in Q4 2024, closing a stake of 510 shares — an estimated $258K sold.

New Century Financial Group first reported a position in IDXX in Q4 2023 and held it in 4 quarters. The position peaked at $523K in Q4 2023. 1,125 funds tracked by Wall St. Rank hold IDXX as of Q4 2024.

  • New Century Financial Group reported no remaining Idexx Laboratories position as of Q4 2024 after selling out during the quarter.
  • New Century Financial Group sold 510 Idexx Laboratories shares in Q4 2024, an estimated $258K.
  • New Century Financial Group first reported a position in Idexx Laboratories in Q4 2023 and held it in 4 quarters.
  • New Century Financial Group's Idexx Laboratories position peaked at $523K in Q4 2023.
  • 1,125 funds tracked by Wall St. Rank held Idexx Laboratories as of Q4 2024.

Based on New Century Financial Group's 13F filing for Q4 2024, filed 17 Jan 2025.